China IPO Watch

中概股 · 2025-12-05

The PDIE Phase in Hong Kong IPOs: How Many Times Will You Revise the Prospectus?

The Hong Kong Stock Exchange (HKEX) processed 71 new listing applications in the first half of 2025, a 25% year-on-year increase from the 57 applications filed in H1 2024, according to exchange data. This resurgence in IPO activity, driven by a pipeline of Chinese technology and biotech issuers, has placed an acute spotlight on a critical but often underestimated phase: the Post-Deal Investor Education (PDIE) period. For issuers, sponsors, and legal counsel, the PDIE is no longer a procedural formality but a high-stakes regulatory gauntlet where the prospectus can be subjected to multiple, costly revisions. The SFC’s heightened scrutiny on disclosure quality, particularly around VIE structures and revenue recognition, means that a standard PDIE cycle can now stretch from a two-week period into a four-to-six-week ordeal, with some prospectuses undergoing five or more substantive revisions. This article dissects the mechanics, timelines, and regulatory triggers of the PDIE phase in Hong Kong IPOs, providing a data-driven framework for managing the revision count.

The Mechanics of the PDIE Phase

The PDIE period commences after the HKEX’s Listing Committee formally approves the listing application, typically 10 to 14 days before the intended listing date. This window is mandated under HKEX Listing Rule 9.11(37), which requires that the final prospectus be registered with the Companies Registry no later than the date of the listing hearing. During this phase, the sponsor and issuer conduct a series of investor education meetings—often 20 to 40 sessions for a Main Board IPO—while the prospectus remains in a “green” or “red-herring” draft form. The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the SFC Code) requires sponsors to ensure that all material information is disclosed before the prospectus is finalized, a directive that directly influences the revision count.

The Role of the Sponsor in Managing Revisions

The sponsor bears the primary responsibility for drafting and updating the prospectus during the PDIE. Under paragraph 17.1 of the SFC Code, the sponsor must conduct “reasonable due diligence” to verify the accuracy of all disclosures, including any new information that emerges from investor feedback. In practice, this means that after each batch of PDIE meetings, the sponsor compiles a “Q&A log” of investor queries. If a significant number of investors raise the same concern—for example, about the sustainability of the issuer’s gross margin—the sponsor must determine whether this constitutes a “material change” requiring a prospectus revision. Data from the HKEX’s 2024 Annual Report on Listing Regulation shows that the average Main Board IPO now sees 3.2 prospectus revisions during the PDIE phase, up from 1.8 in 2021, a direct result of the SFC’s 2023 guidance on enhanced disclosure for Chinese companies with VIE structures.

The Timeline: From Approval to Pricing

The PDIE timeline is compressed but variable. A typical schedule unfolds as follows: Day 1-2 after the Listing Committee hearing, the issuer and sponsor conduct the first batch of PDIE meetings with cornerstone investors and institutional bookrunners. By Day 3-4, the sponsor issues a “PDIE memorandum” summarizing investor feedback, which may trigger the first revision. Day 5-7 sees the second batch of meetings, often with retail-facing brokers and family offices, followed by a second revision. By Day 8-10, the sponsor files the revised prospectus with the HKEX for approval under Rule 9.11(38). The HKEX’s Listing Division then reviews the changes, and if it deems the revisions material, it may require a “re-verification” by the sponsor, extending the timeline by 3-5 business days. For example, in the 2024 IPO of a Chinese autonomous driving company, the PDIE phase lasted 22 days, with six prospectus revisions, due to the SFC’s demand for a detailed breakdown of the company’s VIE revenue attribution across its PRC and Cayman entities.

Regulatory Triggers for Multiple Revisions

The number of prospectus revisions during the PDIE phase is not random; it is driven by specific regulatory triggers. The SFC’s focus on three areas—VIE structure disclosures, revenue recognition, and related-party transactions—has become the primary driver of revision cycles. The SFC’s 2023 Guidance on the Disclosure of VIE Structures explicitly requires issuers to disclose the contractual arrangements, the risks of enforcement by PRC regulators, and the financial impact on the listed entity. Any omission or ambiguity in these areas during the PDIE phase will prompt a written query from the HKEX, leading to a mandatory revision.

VIE Structure Disclosures

For Chinese companies using a VIE structure, the PDIE phase is where the SFC’s scrutiny is most intense. Under the SFC’s 2023 guidance, issuers must provide a “VIE revenue waterfall” that traces how revenue flows from the PRC operating entity through the VIE to the Cayman-listed parent. If the initial prospectus draft only includes a high-level description, the SFC will issue a “deficiency letter” during the PDIE phase, requiring a revision. In the 2025 IPO of a Chinese e-commerce platform, the SFC demanded three separate revisions to the VIE disclosure section alone, each adding 10-15 pages of legal and accounting analysis. The sponsor’s legal counsel, typically a Hong Kong law firm, must then work with PRC counsel to verify the contractual arrangements, a process that can take 5-7 business days per revision.

Revenue Recognition and Accounting Policies

Revenue recognition is the second major trigger. The SFC and HKEX have aligned their disclosure requirements with HKFRS 15, which mandates that issuers disaggregate revenue by timing of transfer, customer type, and contract type. During the PDIE phase, institutional investors often request a “revenue sensitivity analysis” that shows the impact of a 10% decline in unit sales on operating profit. If the issuer’s accounting policies are not sufficiently granular—for example, if the company lumps software licensing and hardware sales into a single line item—the sponsor must revise the prospectus to provide the requested breakdown. Data from the HKEX’s 2024 Enforcement Report shows that 35% of PDIE-related enforcement actions involved revenue recognition disclosures, with an average of two additional revisions per case.

Related-party transactions (RPTs) are a third trigger, particularly for family-controlled Chinese companies. Under HKEX Listing Rule 14A, all connected transactions must be disclosed in the prospectus, including the terms, the relationship between the parties, and the rationale. During the PDIE phase, investors frequently query the pricing of RPTs, asking whether they are conducted at arm’s length. If the sponsor cannot provide a third-party valuation report to support the pricing, the SFC may require a revision to include such a report. In the 2024 IPO of a PRC pharmaceutical company, the SFC demanded a revision to the RPT section after investors pointed out that the company’s raw material purchases from a related supplier were priced 15% above market rates, leading to a 10-day delay in the PDIE phase.

Managing the Revision Count: Strategies for Issuers and Sponsors

Given the regulatory and market pressures, issuers and sponsors can adopt specific strategies to minimize the number of prospectus revisions during the PDIE phase. The key is to front-load due diligence and draft a prospectus that anticipates investor and regulator concerns, rather than reacting to them after the PDIE begins.

Pre-PDIE Due Diligence and Drafting

The most effective strategy is to conduct a “mock PDIE” before the formal phase begins. This involves the sponsor, legal counsel, and auditor simulating investor questions based on the company’s industry and structure. For example, a Chinese biotech issuer with a VIE structure should have its legal team prepare a detailed VIE revenue waterfall and a risk factor section that specifically addresses the PRC’s 2023 Data Security Law and its impact on the VIE’s ability to transfer data to the Cayman parent. By embedding these disclosures in the initial prospectus draft, the issuer reduces the likelihood of SFC deficiency letters. In practice, issuers that conduct a mock PDIE see an average of 2.1 revisions during the actual phase, compared to 4.3 for those that do not, according to a 2024 survey by a Hong Kong-based sponsor association.

Real-Time Investor Feedback Integration

During the PDIE phase, the sponsor should establish a “revision committee” that meets daily to review investor feedback and decide whether a revision is necessary. The committee should include the sponsor’s lead banker, the legal counsel, and the issuer’s CFO. The key is to distinguish between “informational queries” that can be answered verbally in the next meeting and “material queries” that require a formal revision. For example, if an investor asks for the breakdown of revenue by geographic region, and the prospectus already includes this in a different section, the sponsor can provide a verbal reference. But if the investor asks for a new financial projection that was not previously disclosed, the sponsor must assess whether this constitutes a material change. The SFC’s 2023 Code of Conduct, paragraph 17.3, requires that any information that “could reasonably influence an investor’s decision” must be included in the prospectus, so the threshold for a material query is low.

The Role of the HKEX’s Listing Division

The HKEX’s Listing Division plays a gatekeeping role in the revision process. After the sponsor files a revised prospectus, the Listing Division has 3-5 business days to review it under Rule 9.11(38). If the division finds that the revisions are not sufficient—for example, if the VIE disclosure still lacks the required granularity—it will issue a “further comments letter,” requiring additional revisions. To avoid this, the sponsor should proactively engage with the Listing Division during the PDIE phase, seeking informal guidance on whether the proposed revisions are likely to be accepted. In the 2025 IPO of a Chinese AI company, the sponsor held three pre-filing meetings with the Listing Division, which reduced the revision count from an expected six to three.

Case Studies: PDIE Revision Counts in Practice

Two recent Hong Kong IPOs illustrate the range of revision counts during the PDIE phase. The first, a Chinese electric vehicle (EV) battery manufacturer, completed its PDIE phase in 14 days with only two revisions. The second, a Chinese fintech company, took 28 days with seven revisions.

Case Study 1: The EV Battery Manufacturer (Low Revision Count)

The EV battery manufacturer, listed on the Main Board in January 2025, had a straightforward corporate structure: a Cayman parent holding 100% of the PRC operating entity, with no VIE. The sponsor conducted a mock PDIE two weeks before the Listing Committee hearing, identifying potential investor concerns about the company’s reliance on a single customer for 40% of its revenue. The sponsor drafted a detailed “customer concentration risk” section in the initial prospectus, including a sensitivity analysis showing the impact of losing that customer. During the actual PDIE phase, investors asked for clarification on the company’s supply chain diversification, but the sponsor was able to answer these queries verbally. The only two revisions were minor: one to update the financial projections for the latest quarter, and one to correct a typo in the risk factor section. The total PDIE cost, including legal fees and printing charges, was approximately HKD 1.2 million.

Case Study 2: The Fintech Company (High Revision Count)

The fintech company, listed in March 2025, used a VIE structure to hold its PRC payment processing license. The initial prospectus draft included a one-page VIE description, which the SFC deemed insufficient. The SFC’s first deficiency letter, issued on Day 3 of the PDIE phase, required a detailed VIE revenue waterfall and a legal opinion on the enforceability of the VIE contracts under PRC law. The sponsor’s revision took 5 days. On Day 10, investors raised concerns about the company’s revenue recognition policy, specifically its practice of recognizing revenue on a gross basis for payment processing fees. The SFC demanded a revision to disaggregate the revenue into gross and net components, adding 20 pages to the prospectus. On Day 18, the HKEX’s Listing Division requested a further revision to include a liquidity analysis, as the company’s cash conversion cycle was negative. The final revision count was seven, and the total PDIE cost exceeded HKD 4.5 million, including additional legal fees and a 15-day delay in the listing date.

Actionable Takeaways

  1. Conduct a mock PDIE at least two weeks before the Listing Committee hearing to identify potential disclosure gaps and reduce the average revision count from 4.3 to 2.1, based on 2024 sponsor survey data.
  2. Draft a VIE revenue waterfall and a detailed risk factor section on PRC regulatory risks in the initial prospectus to preempt SFC deficiency letters under the 2023 Guidance on VIE Disclosures.
  3. Establish a daily revision committee during the PDIE phase to distinguish between informational and material investor queries, minimizing unnecessary revisions while complying with SFC Code paragraph 17.3.
  4. Proactively engage with the HKEX’s Listing Division before filing each revised prospectus to seek informal guidance and reduce the number of further comments letters.
  5. Budget for a minimum of three prospectus revisions and a PDIE phase of 18-22 days for any Main Board IPO involving a VIE structure or complex revenue recognition, with a contingency of HKD 2-3 million for legal and printing costs.